Table 1.
Characteristics | Total | mTOR-high | mTOR-low | P value |
---|---|---|---|---|
N = 148 | N = 94 | N = 54 | ||
Gender | 0.686 | |||
Male | 114 | 71 | 43 | |
Female | 34 | 23 | 11 | |
Age | 0.473 | |||
<65 | 51 | 30 | 21 | |
⩾65 | 97 | 64 | 33 | |
Tumor length | 0.302 | |||
<5 | 64 | 44 | 20 | |
⩾5 | 84 | 50 | 34 | |
pT status | <0.001 | |||
pT1 | 21 | 6 | 15 | |
pT2 | 37 | 11 | 26 | |
pT3 | 76 | 64 | 12 | |
pT4 | 14 | 13 | 1 | |
pN status | <0.001 | |||
pN0 | 56 | 19 | 37 | |
PN1 | 92 | 75 | 17 | |
TNM stage (AJCC) | <0.001 | |||
I | 20 | 6 | 14 | |
II | 46 | 16 | 30 | |
III | 82 | 72 | 10 | |
Differentiation grade | 0.007 | |||
Well | 20 | 13 | 7 | |
Moderate | 81 | 43 | 38 | |
Poor | 47 | 38 | 9 |
AJCC: American Joint Commission on Cancer Staging; pT: pathological tumor stage; pN: pathological node stage.